<i>In Vitro</i> Screening for Antihepatic Steatosis Active Components within Coptidis Rhizoma Alkaloids Extract Using Liver Cell Extraction with HPLC Analysis and a Free Fatty Acid-Induced Hepatic Steatosis HepG2 Cell Assay

<table>The trend chart of the rate of TG accumulation inhibition following treatment with alkaloids at different concentrations on a hepatic steatosis HepG2 cell model.</table>

Evidence-Based Complementary and Alternative Medicine

fig3

Figure 3

Figure 3: <i>In Vitro</i> Screening for Antihepatic Steatosis Active Components within Coptidis Rhizoma Alkaloids Extract Using Liver Cell Extraction with HPLC Analysis and a Free Fatty Acid-Induced Hepatic Steatosis HepG2 Cell Assay 

Figure 3 | In Vitro Screening for Antihepatic Steatosis Active Components within Coptidis Rhizoma Alkaloids Extract Using Liver Cell Extraction with HPLC Analysis and a Free Fatty Acid-Induced Hepatic Steatosis HepG2 Cell Assay 